Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML blood cancer cells. The company's eHSCs targeted therapies, such as CAR-Ts, bispecific antibodies, and antibody-drug conjugates provide treatment for blood cancers. Vor Biopharma, Inc. has a collaboration agreement with Akron BioProducts to develop and manufacture cGMP nucleases. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Over the last 12 months, insiders at Vor Biopharma Inc. have bought $0 and sold $20,357 worth of Vor Biopharma Inc. stock.
On average, over the past 5 years, insiders at Vor Biopharma Inc. have bought $73.63M and sold $5.07M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,979,566 shares for transaction amount of $53.63M was made by RA CAPITAL MANAGEMENT, L.P. () on 2021‑02‑09.
2024-06-03 | Sale | Attar Eyal C. | CHIEF MEDICAL OFFICER | 14,645 0.0209% | $1.39 | $20,357 | -13.29% | |
2021-11-16 | Sale | PARMAR KUSH | 330,706 0.7914% | $15.30 | $5.06M | -69.06% | ||
2021-11-16 | Sale | 5AM Ventures VI, L.P. | 10 percent owner | 330,706 0.7914% | $15.30 | $5.06M | -69.06% | |
2021-02-09 | RA CAPITAL MANAGEMENT, L.P. | 2.98M 5.6047% | $18.00 | $53.63M | -63.24% | |||
2021-02-09 | PARMAR KUSH | 555,555 1.045% | $18.00 | $10M | -63.24% | |||
2021-02-09 | 5AM Ventures VI, L.P. | 10 percent owner | 555,555 1.045% | $18.00 | $10M | -63.24% |
Attar Eyal C. | CHIEF MEDICAL OFFICER | 96063 0.1407% | $1.15 | 0 | 1 | |
RA CAPITAL MANAGEMENT, L.P. | 8297265 12.2368% | $1.15 | 1 | 0 | <0.0001% | |
PARMAR KUSH | 1766634 2.6054% | $1.15 | 1 | 1 | <0.0001% | |
5AM Ventures VI, L.P. | 10 percent owner | 1766634 2.6054% | $1.15 | 1 | 1 | <0.0001% |
RA Capital Management, L.P. | $53.91M | 33.33 | 22.75M | 0% | +$0 | 0.05 | |
Fidelity Investments | $18.03M | 11.15 | 7.61M | -0.14% | -$24,906.33 | <0.01 | |
Paradigm BioCapital Advisors LP | $15.3M | 9.46 | 6.46M | 0% | +$0 | 0.56 | |
5Am Venture Management Llc | $15.08M | 9.32 | 6.36M | 0% | +$0 | 1.02 | |
Laurion Capital Management LP | $7.54M | 4.66 | 3.18M | 0% | +$0 | 0.21 | |
BlackRock | $5.33M | 3.29 | 2.25M | -0.18% | -$9,368.61 | <0.0001 | |
The Vanguard Group | $4.3M | 2.66 | 1.81M | +3.98% | +$164,563.30 | <0.0001 | |
Woodline Partners LP | $2.63M | 1.63 | 1.11M | 0% | +$0 | 0.03 | |
Johnson & Johnson | $2.55M | 1.57 | 1.07M | 0% | +$0 | 0.06 | |
Artal Group S A | $2.37M | 1.47 | 1M | -57.4% | -$3.19M | 0.01 | |
Geode Capital Management | $1.99M | 1.23 | 841,208 | +5.94% | +$111,746.60 | <0.0001 | |
State Street | $1.56M | 0.96 | 657,707 | +8.17% | +$117,789.03 | <0.0001 | |
Sarissa Capital Management LP | $1.46M | 0.91 | 618,000 | 0% | +$0 | 0.26 | |
Northern Trust | $944,118.00 | 0.58 | 398,362 | +0.29% | +$2,704.17 | <0.0001 | |
MAI Capital Management, LLC | $867,086.00 | 0.54 | 365,859 | +2.44% | +$20,637.96 | 0.01 | |
Ensign Peak Advisors Inc | $820,226.00 | 0.51 | 346,087 | 0% | +$0 | <0.01 | |
Renaissance Technologies | $793,000.00 | 0.49 | 334,658 | +548.56% | +$670,729.50 | <0.01 | |
Millennium Management LLC | $375,389.00 | 0.23 | 158,392 | New | +$375,389.00 | <0.0001 | |
Exchange Traded Concepts, LLC | $366,013.00 | 0.23 | 154,436 | +156.67% | +$223,410.23 | 0.01 | |
Bridgeway Capital Management | $314,499.00 | 0.19 | 132,700 | -18.44% | -$71,100.00 | 0.01 | |
Morgan Stanley | $300,261.00 | 0.19 | 126,692 | -26.37% | -$107,524.87 | <0.0001 | |
BNY Mellon | $247,787.00 | 0.15 | 104,551 | -3.38% | -$8,669.50 | <0.0001 | |
Charles Schwab | $246,286.00 | 0.15 | 103,918 | 0% | +$0 | <0.0001 | |
Goldman Sachs | $220,815.00 | 0.14 | 93,171 | +143.04% | +$129,958.79 | <0.0001 | |
Marshall Wace | $180,864.00 | 0.11 | 76,314 | New | +$180,864.00 | <0.0001 | |
Nuveen | $169,464.00 | 0.11 | 71,504 | 0% | +$0 | <0.0001 | |
The Bollard Group | $132,000.00 | 0.08 | 55,555 | 0% | +$0 | <0.01 | |
Acadian Asset Management | $126,000.00 | 0.08 | 53,708 | New | +$126,000.00 | <0.0001 | |
Citadel Advisors LLC | $106,835.00 | 0.07 | 45,078 | +47.09% | +$34,203.89 | <0.0001 | |
RhumbLine Advisers | $103,489.00 | 0.06 | 43,670 | +1.58% | +$1,611.46 | <0.0001 | |
LMR PARTNERS LLP | $96,926.00 | 0.06 | 40,897 | -19.98% | -$24,207.21 | <0.01 | |
UBS | $90,968.00 | 0.06 | 38,383 | +1.19% | +$1,066.50 | <0.0001 | |
Barclays | $91,000.00 | 0.06 | 38,475 | -26.12% | -$32,178.17 | <0.0001 | |
Deutsche Bank | $75,449.00 | 0.05 | 31,835 | 0% | +$0 | <0.0001 | |
Bourgeon Capital Management, LLC. | $69,797.00 | 0.04 | 29,450 | 0% | +$0 | 0.01 | |
Bank of America | $67,882.00 | 0.04 | 28,642 | -46.51% | -$59,011.03 | <0.0001 | |
Susquehanna International Group | $62,997.00 | 0.04 | 26,581 | -58.19% | -$87,685.30 | <0.0001 | |
Dimensional Fund Advisors | $59,058.00 | 0.04 | 24,919 | +21.64% | +$10,506.20 | <0.0001 | |
Bank of Montreal | $53,297.00 | 0.03 | 22,488 | New | +$53,297.00 | <0.0001 | |
New York State Common Retirement Fund | $52,000.00 | 0.03 | 21,867 | +1.73% | +$884.62 | <0.0001 | |
Jane Street Capital | $46,196.00 | 0.03 | 19,492 | +15.03% | +$6,036.39 | <0.0001 | |
Money Concepts | $47,400.00 | 0.03 | 20,000 | New | +$47,400.00 | 0.01 | |
American International Group | $44,577.00 | 0.03 | 18,809 | +0.44% | +$194.34 | <0.0001 | |
Xtx Topco Ltd | $44,189.00 | 0.03 | 18,645 | New | +$44,189.00 | <0.01 | |
Chicago Partners Wealth Advisors | $33,942.00 | 0.03 | 18,054 | +4.24% | +$1,379.94 | <0.01 | |
HSBC | $41,961.00 | 0.03 | 17,705 | New | +$41,961.00 | <0.0001 | |
Invesco | $41,196.00 | 0.03 | 17,382 | -3.64% | -$1,554.74 | <0.0001 | |
JPMorgan Chase | $38,363.00 | 0.02 | 16,187 | -33.92% | -$19,696.97 | <0.0001 | |
Walleye Capital | $39,224.00 | 0.02 | 16,550 | New | +$39,224.00 | <0.0001 | |
Voya Investment Management LLC | $34,761.00 | 0.02 | 14,667 | -7.72% | -$2,908.01 | <0.0001 |